Alzamend Neuro Inc [ALZN] stock is trading at $3.83, up 9.43%. An important factor to consider is whether the stock is rising or falling in short-term value. The ALZN shares have gain 11.01% over the last week, with a monthly amount drifted -36.48%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alzamend Neuro Inc [NASDAQ: ALZN] stock has seen the most recent analyst activity on October 01, 2021, when Ascendiant Capital Markets initiated its Buy rating and assigned the stock a price target of $8.
Alzamend Neuro Inc [ALZN] stock has fluctuated between $3.06 and $135.54 over the past year. Alzamend Neuro Inc [NASDAQ: ALZN] shares were valued at $3.83 at the most recent close of the market.
Analyzing the ALZN fundamentals
Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -55.29%, Pretax Profit Margin comes in at -55.54%, and Net Profit Margin reading is -55.54%. To continue investigating profitability, this company’s Return on Assets is posted at -1.01, Equity is -4.98 and Total Capital is -1.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.59 points at the first support level, and at 3.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.19, and for the 2nd resistance point, it is at 4.54.
Ratios To Look Out For
For context, Alzamend Neuro Inc’s Current Ratio is 5.44. On the other hand, the Quick Ratio is 5.44, and the Cash Ratio is 4.63.
Transactions by insiders
Recent insider trading involved AULT MILTON C III, Director, that happened on May 12 ’25 when 1213.0 shares were sold. Director, AULT MILTON C III completed a deal on May 12 ’25 to sell 11.0 shares. Meanwhile, 10% Owner Hyperscale Data, Inc. bought 0.52 million shares on May 12 ’25.
